Risks and benefits of statin use in young people with type 1 diabetes. - Wikidata - wikimedia - TriplyDB

Risks and benefits of statin use in young people with type 1 diabetes.

Risks and benefits of statin use in young people with type 1 diabetes.

http://www.wikidata.org/entity/Q38209424

about

Insulin sensitivity and complications in type 1 diabetes: New insights Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetes ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes.Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes.Physiologically Based Pharmacokinetic (PBPK) Modeling of Pitavastatin and Atorvastatin to Predict Drug-Drug Interactions (DDIs).Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of M Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.

P2860

Q27000205-150C067E-4BF4-4034-97A8-95088125DA2D Q33664505-43A59435-1A08-44EC-9B3F-D9793771E973 Q34614907-236DD345-F8EA-47B3-BDAF-0FAF98EE8B54 Q34762311-65F817E1-779E-458D-B136-FA1642BA0F4B Q35667553-75448C6A-E549-4FA8-A87D-931847953A57 Q39178447-712891AB-E207-4C27-A237-8710ABEB2A74 Q47725249-175A02E6-E4BC-4C23-877E-BA7324E246AD Q55176268-98F98E1F-70F3-4533-AE56-BFF4F68B0C3A

P2860

Risks and benefits of statin use in young people with type 1 diabetes.

http://www.wikidata.org/entity/Q38209424

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Risks and benefits of statin use in young people with type 1 diabetes.

@en

type

label

Risks and benefits of statin use in young people with type 1 diabetes.

@en

prefLabel

Risks and benefits of statin use in young people with type 1 diabetes.

@en

P1433

Q38209424-E36BF4CB-530B-4B33-A581-E77ED1768F97

P1476

Q38209424-B2B16805-0288-46DA-A428-D1F736EDB2B4

P2093

Q38209424-9D558CE6-A72A-4B12-943A-54D794C04961

P2860

Q38209424-07A8EDD1-E6A1-456E-9F56-BBD3083BCE12

Q38209424-0A1BA7AD-17F6-48B4-8390-CF6FBA5B3D82

Q38209424-0B081E96-EB8C-4400-8783-0511DDF73CA4

Q38209424-10489C6F-0C55-4913-805E-7D8F52C8D8E8

Q38209424-119CC525-788B-4901-A129-E0006BC8B0A0

Q38209424-187DA1B0-5EFC-4D9D-BFC8-0C61E3D78884

Q38209424-1999DEA1-4409-49A8-ABF7-A72579A568E8

Q38209424-1B07614B-9ACF-4BB8-BAF5-9F94F07887A5

Q38209424-2236CC2D-9F35-4B71-B6F3-A205F7D9EDED

Q38209424-3907E11F-6522-4D7A-B8D3-E19F167EBF96

P2888

Q38209424-19EC32EE-7E23-4A3A-8CBF-161A5027102B

P304

Q38209424-11283CBD-8DCB-4E8A-A712-0F59722CE5A3

P31

Q38209424-68546639-5718-4E72-B694-96A514235A1A

P356

Q38209424-6B2595C5-1247-4639-A074-5E0876F6B7C0

P433

Q38209424-DAC56BBD-B383-4D26-9A4F-BDB92EB2050D

P478

Q38209424-C910CF72-E655-4D5F-8B62-40388678997C

P50

Q38209424-B49BAD53-71C2-4B49-A94B-C92E9ABBC559

P577

Q38209424-4D73A0F8-447D-4D6B-9FF8-C9E412524A1F

P6179

Q38209424-D7719947-E780-43ED-961A-8A97E32900AA

P698

Q38209424-E74DE37B-A2CF-4058-97E5-20DD7C972584

P921

Q38209424-F55EE02C-8665-49D3-9A62-068E25DCDF9D

P932

Q38209424-FEEFA6F4-AFD4-4F5E-BDB8-7CD2D33F0AD3

P356

S11892-014-0499-8

P1433

Current diabetes report

P1476

Risks and benefits of statin use in young people with type 1 diabetes

@en

P2093

R Paul Wadwa

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

Statins for children with familial hypercholesterolemia

Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology?

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Standards of medical care in diabetes--2013

P2888

s11892-014-0499-8

P304

499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-014-0499-8

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Petter Bjornstad

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043089471

http://www.w3.org/2001/XMLSchema#string

P698

24796934

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

7041430

http://www.w3.org/2001/XMLSchema#string